Rouach V - Search Results

1

Adherence With Bisphosphonates and Long-Term Risk of Hip Fractures: A Nested Case-Control Study Using Real-World Data.

Shalev V, Sharman Moser S, Goldshtein I, Yu J, Weil C, Ish-Shalom S, Rouach V, Chodick G. Shalev V, et al. Among authors: rouach v. Ann Pharmacother. 2017 Sep;51(9):757-767. doi: 10.1177/1060028017710482. Epub 2017 May 23. Ann Pharmacother. 2017. PMID: 28535690

2

Cost and Consequences of Nonadherence With Oral Bisphosphonate Therapy: Findings From a Real-World Data Analysis.

Sharman Moser S, Yu J, Goldshtein I, Ish-Shalom S, Rouach V, Shalev V, Modi A, Chodick G. Sharman Moser S, et al. Among authors: rouach v. Ann Pharmacother. 2016 Apr;50(4):262-9. doi: 10.1177/1060028015626935. Epub 2016 Jan 18. Ann Pharmacother. 2016. PMID: 26783359

3

Role of Side Effects, Physician Involvement, and Patient Perception in Non-Adherence with Oral Bisphosphonates.

Goldshtein I, Rouach V, Shamir-Stein N, Yu J, Chodick G. Goldshtein I, et al. Among authors: rouach v. Adv Ther. 2016 Aug;33(8):1374-84. doi: 10.1007/s12325-016-0360-3. Epub 2016 Jun 21. Adv Ther. 2016. PMID: 27329383

4

Vertebral Fractures Following Denosumab Discontinuation in Patients with Prolonged Exposure to Bisphosphonates.

Tripto-Shkolnik L, Rouach V, Marcus Y, Rotman-Pikielny P, Benbassat C, Vered I. Tripto-Shkolnik L, et al. Among authors: rouach v. Calcif Tissue Int. 2018 Jul;103(1):44-49. doi: 10.1007/s00223-018-0389-1. Epub 2018 Feb 2. Calcif Tissue Int. 2018. PMID: 29396698

5

Exposure to alendronate is associated with a lower risk of bone metastases in osteoporotic women with early breast cancer.

Rouach V, Goldshtein I, Wolf I, Catane R, Chodick G, Iton A, Stern N, Cohen D. Rouach V, et al. J Bone Oncol. 2018 Aug 8;12:91-95. doi: 10.1016/j.jbo.2018.07.011. eCollection 2018 Sep. J Bone Oncol. 2018. PMID: 30148062 Free PMC article.

6

The association between adherence with oral bisphosphonates and the risk of breast cancer in post-menopausal women.

Rouach V, Goldshtein I, Buch A, Catane R, Chodick G, Stern N, Shalev V, Cohen D. Rouach V, et al. J Bone Oncol. 2018 Nov 6;16:100202. doi: 10.1016/j.jbo.2018.10.001. eCollection 2019 Jun. J Bone Oncol. 2018. PMID: 31334001 Free PMC article.

7

Fracture incidence after denosumab discontinuation: Real-world data from a large healthcare provider.

Tripto-Shkolnik L, Fund N, Rouach V, Chodick G, Shalev V, Goldshtein I. Tripto-Shkolnik L, et al. Among authors: rouach v. Bone. 2020 Jan;130:115150. doi: 10.1016/j.bone.2019.115150. Epub 2019 Nov 9. Bone. 2020. PMID: 31715340

8

Development and efficacy of a computerized decision support system for osteoporosis management in the community.

Goldshtein I, Shamai-Lubovitz O, Guindy M, Shalev V, Chodick G, Lerner U, Rouach V. Goldshtein I, et al. Among authors: rouach v. Arch Osteoporos. 2020 Feb 26;15(1):27. doi: 10.1007/s11657-020-00718-3. Arch Osteoporos. 2020. PMID: 32103347

9

DXA assessment and fracture prevention in hormone positive breast cancer patients after treatment initiation with aromatase inhibitors: A registry-based cohort study.

Rouach V, Greenman Y, Chodick G, Goldshtein I. Rouach V, et al. J Bone Oncol. 2023 Aug 25;42:100501. doi: 10.1016/j.jbo.2023.100501. eCollection 2023 Oct. J Bone Oncol. 2023. PMID: 37664159 Free PMC article.

10

Association between abdominal obesity and fragility fractures among elderly Israeli women.

Ofir O, Buch A, Rouach V, Goldsmith R, Stern N, Monsonego-Ornan E. Ofir O, et al. Among authors: rouach v. Aging Clin Exp Res. 2020 Aug;32(8):1459-1467. doi: 10.1007/s40520-019-01347-8. Epub 2019 Sep 14. Aging Clin Exp Res. 2020. PMID: 31522392

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters